Estradiol Enanthate Powder
Contact : Miss.Fueng
Email us at sue@yccreate.com
Whatsapp : +86 189 6116 7067
Synonyms:
EE; E2E; E2-EN; EEn; Estradiol enanthate; Estradiol heptanoate; SQ-16150
Quick Detail:
CAS: 4956-37-0
MF: C25H36O3
MW: 384.55
MOQ: As your required
Standard:Enterprise standard
Description:
Estradiol cypionate, is an estrogen medication which is used in hormone therapy for menopausal symptoms and low estrogen levels in women, in hormone therapy for transgender women, and in hormonal birth control for women.
Application:
Examples of indications for the drug include hormone therapy and hormonal contraception.
COA:
Product name | Estradiol Enanthate |
Description | White or almost white crystalline powder |
Usage | Pharmaceutical material |
Packing and Delivery:
Delivery Time: Within 24 hours after receiving your payment
Payment Terms: Western Union, MoneyGram, T/T，L/C
Packing: foil bag or tin.
Package: Discreet Packing ways for your choice.
Well disguised packing. Fast and secure delivery by DHL, FedEx, HKEMS, UPS, etc.
Our Services:
Any Inquiries will be replied within 24 hours.
Any questions or problems after receiving the product, please feel free to contact us. Problems would be solved immediately.
Exclusive customer service and we always online if you need any help.Our after-sales service is also helpful.
Advantages:
1. Rich experience: Our company is a professional production leading factory in China in pharmaceutical area of many years.
2. Top quality: High quality guaranteed, once any problem is found, the package would be reshipped for you .
3. Security Shipping: Shipping by express (FedEx,UPS,DHL,EMS), by air. The most professional forwarder would be recommanded for you.
4. Fast delivery: We have stock, so we can delivery quickly once payment is received.
5. Quality service: We will give you warm after-sale service,if any question we will reply you within 24 hours.
6. Competitive prices: A discount would be given when you make a large order.
Any other question, please feel free to contact me.
